Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| SFP3-3 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Society of Family Planning | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study is being done in order to gain information on the most suitable types of birth control in women who recently had gestational diabetes, or diabetes diagnosed during pregnancy. The intrauterine device (IUD) is a highly effective form of birth control. It is inserted into the uterus and prevents pregnancy for either 5 or 10 years, depending on the type of IUD (hormone-releasing or copper). The hormone-releasing IUD works for 5 years and releases a hormone called a progestin into the uterus. The copper IUD contains no hormones and works for 10 years. The IUD is an excellent form of birth control postpartum, but it is unknown if the hormone-releasing IUD will affect blood sugars and increase a woman's risk of becoming diabetic when she's not pregnant. The hypothesis is that the hormone-containing IUD will NOT increase blood sugars, so women who use the hormone-containing IUD will have similar blood sugars to those who use the copper IUD or have had their tubes tied (no hormones).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Levonorgestrel IUD |
| ||
| Copper IUD or Tubal Ligation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mirena (Levonorgestrel IUD) | Device | Release of intrauterine levonorgestrel for contraception, approved for up to 5 years' use |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glucose tolerance at 12 months postpartum. | 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Postpartum women with gestational diabetes in the last pregnancy
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jessica W Kiley, MD, MPH | Northwestern Universeity | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Northwestern Medical Faculty Foundation; Northwestern Memorial Hospital | Chicago | Illinois | 60611 | United States |
Not provided
Not provided
Not provided
Not provided
| Paragard (Copper IUD ) or Tubal Ligation | Device | Copper IUD placed to provide contraception for up to 10 years |
|
|
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| D018149 | Glucose Intolerance |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D006943 | Hyperglycemia |
Not provided
Not provided
| ID | Term |
|---|---|
| D013246 | Sterilization, Tubal |
| ID | Term |
|---|---|
| D013509 | Gynecologic Surgical Procedures |
| D013519 | Urogenital Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D013245 | Sterilization, Reproductive |
Not provided
Not provided